The Potent Inhibitory Effect of ?-D-Mannuronic Acid (M2000) as a Novel NSAID with Immunosuppressive Property on Anti-Cyclic Citrullinated Peptide Antibodies, Rheumatoid Factor and Anti-dsDNA Antibodies in Patients with Rheumatoid Arthritis

Publisher： Bentham Science Publishers

E-ISSN： 1875-6220|14|3|206-214

ISSN： 1570-1638

Source： Current Drug Discovery Technologies, Vol.14, Iss.3, 2017-08, pp. : 206-214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis

By  

Arthritis & Rheumatism, Vol. 48, Iss. 10, 2003-10 ,pp. : 2741-2749

John Wiley & Sons Inc

Access to resources Recommend Favorite

Relatives Without Rheumatoid Arthritis Show Reactivity to Anti–Citrullinated Protein/Peptide Antibodies That Are Associated With Arthritis‐Related Traits: Studies of the Etiology of Rheumatoid Arthritis

By  

Arthritis & Rheumatism, Vol. 65, Iss. 8, 2013-08 ,pp. : 1995-2004

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Effect of Anti-B-cell Therapy on the Development of Atherosclerosis in Patients with Rheumatoid Arthritis

By  

Current Pharmaceutical Design, Vol. 18, Iss. 11, 2012-04 ,pp. : 1512-1518

Bentham Science Publishers

Access to resources Recommend Favorite

ANA+ (anti-nuclear antibody) is correlated with RF+ (rheumatoid factor) in rheumatoid arthritis

By Matsos Mark P.  

Inflammopharmacology, Vol. 12, Iss. 3, 2004-01 ,pp. : 229-231

VSP

Access to resources Recommend Favorite

Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis

By Coenen Marieke JH   Toonen Erik JM   Scheffer Hans   Radstake Timothy RDJ   Barrera Pilar   Franke Barbara  

Pharmacogenomics, Vol. 8, Iss. 7, 2007-07 ,pp. : 761-773

Future Medicine

Access to resources Recommend Favorite